Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07237711

Clinical Investigation of Sensovisc

Clinical Investigation of Sensovisc Sterile Sodium Hyaluronate Gel in the Knee Joint

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Ankara City Hospital Bilkent · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical investigation aims to investigate the safety and performance of Sensovisc. Sensovisc is used to reduce osteoarthritis (OA) related pain in the joints by supporting synovial fluid by intra-articular injection and allowing the synovial fluid to restore its viscoelastic properties. It increases the joint mobility by reducing or eliminating the pain. This Clinical Investigation was designed as a cross-sectional, interventional, and prospective study.

Detailed description

Osteoarthritis (OA) is the most prevalent chronic arthritis and a leading cause of pain and disability among adults. OA is a degenerative joint disease characterized by chronic inflammation, cartilage degradation and erosion of underlying bone in the affected joints, predominantly affects knees, significantly impacting patient mobility and quality of life. * Although there are currently no approved disease-modifying osteoarthritis drugs (DMOADs), nonpharmacologic interventions, such as physical therapy and weight management, and pharmaceutical approaches are available to reduce or revise joint damage and inflammation. * Among various therapeutic interventions, intra-articular hyaluronic acid (HA) injections have emerged as an alternative promising treatment. Emerging evidence suggests that HA may exert chondroprotective effects by enhancing synovial fluid viscosity, improving joint lubrication, and mitigating inflammatory processes, thereby potentially decelerating disease progression and preserving cartilage integrity.

Conditions

Interventions

TypeNameDescription
DEVICESensovisc®Injectable Sterile Sodium Hyaluronate Gel

Timeline

Start date
2025-11-25
Primary completion
2026-08-25
Completion
2026-11-25
First posted
2025-11-20
Last updated
2025-11-20

Source: ClinicalTrials.gov record NCT07237711. Inclusion in this directory is not an endorsement.